113 related articles for article (PubMed ID: 513607)
21. [Hemorheologic effects of hydroxyethyl starch 200/0.5, dextran 40, oxypolygelatine and full electrolyte solution over 48 hours].
Brehme S; Keysser G; Turowski A; Schmidt HH
Z Gesamte Inn Med; 1993 Oct; 48(10):506-10. PubMed ID: 7504854
[TBL] [Abstract][Full Text] [Related]
22. Effect of hemodilution on resting flow and reactive hyperemia in lower limbs.
Rudofsky G; Meyer P; Strohmenger HU
Bibl Haematol; 1981; (47):157-64. PubMed ID: 7337658
[No Abstract] [Full Text] [Related]
23. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
Ernst E; Kollar L; Matrai A
Acta Med Austriaca; 1991; 18 Suppl 1():27-9. PubMed ID: 1719730
[TBL] [Abstract][Full Text] [Related]
24. [Acute perioperative hemodilution without using hydroxyethyl starch : hemodynamic alterations under "controlled" hypovolemia].
Hofmann-Kiefer K; Chappell D; Jacob M; Schülke A; Helfen T; Anetzberger J; Rehm M
Anaesthesist; 2015 Jan; 64(1):26-32. PubMed ID: 25380794
[TBL] [Abstract][Full Text] [Related]
25. Supervised short-stretch compression therapy in mixed leg ulcers.
Stansal A; Tella E; Yannoutsos A; Keita I; Attal R; Gautier V; Sfeir D; Lazareth I; Priollet P
J Med Vasc; 2018 Jul; 43(4):225-230. PubMed ID: 29981730
[TBL] [Abstract][Full Text] [Related]
26. [Arterial ulcers of the lower limbs].
Lazareth I
Soins; 2008; (722):46-50. PubMed ID: 18333347
[No Abstract] [Full Text] [Related]
27. Peripheral vascular disease: flow studies and clinical results after isovolemic hemodilution--case reports.
Caputi CA; De Carolis G
Angiology; 1986 Feb; 37(2):124-7. PubMed ID: 3954151
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of central retinal venous and arterial occlusion by isovolemic hemodilution (author's transl)].
Wiederholt M; Leonhardt H; Schmid-Schönbein H; Hager H
Klin Monbl Augenheilkd; 1980; 177(2):157-64. PubMed ID: 7453050
[TBL] [Abstract][Full Text] [Related]
29. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
Kiesewetter H; Jung F; Birk A; Spitzer S
Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
[TBL] [Abstract][Full Text] [Related]
30. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
Schmid-Schönbein H
Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
[TBL] [Abstract][Full Text] [Related]
31. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization.
Marston WA; Davies SW; Armstrong B; Farber MA; Mendes RC; Fulton JJ; Keagy BA
J Vasc Surg; 2006 Jul; 44(1):108-114. PubMed ID: 16828434
[TBL] [Abstract][Full Text] [Related]
32. [Diluted albumin-dextran 40 combination in treating arteriopathy of the lower extremities by normovolemic hemodilution. The rheological effects].
Stoltz JF; Chevraud C; Voisin P; Burdin D; Streiff F; Laxenaire MC
J Mal Vasc; 1986; 11(4):344-50. PubMed ID: 2433377
[TBL] [Abstract][Full Text] [Related]
33. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.
Morishita R; Aoki M; Hashiya N; Makino H; Yamasaki K; Azuma J; Sawa Y; Matsuda H; Kaneda Y; Ogihara T
Hypertension; 2004 Aug; 44(2):203-9. PubMed ID: 15238569
[TBL] [Abstract][Full Text] [Related]
34. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
35. Isovolemic hemodilution: a therapeutical intervention for improving microcirculation.
Rudofsky G
Int Angiol; 1986; 5(3):151-4. PubMed ID: 3559316
[TBL] [Abstract][Full Text] [Related]
36. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
Angelkort B
Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
[TBL] [Abstract][Full Text] [Related]
37. [Kinetic effects of 6% hydroxyethyl starch 200.000/0.6-0.66 in hypervolemic hemodilution].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():20-2. PubMed ID: 1719728
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of occlusive lesions of upper extremity arteries in patients with thromboangiitis obliterans.
Pokrovskiĭ AV; Kuntsevich GI; Dan VN; Chupin AV; Kalinin AA; Alekperov RT; Makhmudova LS
Angiol Sosud Khir; 2003; 9(2):86-94. PubMed ID: 12811380
[TBL] [Abstract][Full Text] [Related]
39. [Ambulatory hemodilution therapy of peripheral arterial circulation disorders].
Wohlleben E; Wohlleben H; Voigt H; Köhler H
Z Gesamte Inn Med; 1981 Nov; 36(21):838-9. PubMed ID: 7331388
[TBL] [Abstract][Full Text] [Related]
40. [Comparative study of low molecular dextran or hydroxyethyl starch as a volume substitute in hemodilution therapy].
Kiesewetter H; Jung F; Blume J; Bulling B; Franke RP
Klin Wochenschr; 1986 Jan; 64(1):29-37. PubMed ID: 2419635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
